BamSEC and AlphaSense Join Forces
Learn More

NRX Pharmaceuticals Inc. – Indentures

NASDAQ: NRXP    
Share price (6/30/26): $4.09    
Market cap (6/30/26): $148 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from S-3 37 pages NRX Pharmaceuticals, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.4
from 8-K 18 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.3
from 8-K 17 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.2
from 8-K 19 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 31 pages Senior Secured Convertible Note Due November [●], 2025
12/34/56
EX-4.1
from 8-K 20 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.9
from 10-K 13 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.8
from 10-K 5 pages Description of Capital Stock
12/34/56
EX-4.1
from 8-K 20 pages Form of Representative’s Warrant Agreement
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc. Warrant Shares: Issue Date: , 2023
12/34/56
EX-4.2
from 8-K/A 3 pages Re: Amendment to Existing Preferred Investment Options Dear Holder: Reference Is Hereby Made to the Registered Offering on or About the Date Hereof (The “Offering”) by NRX Pharmaceuticals, Inc. (The “Company”) of Its Common Stock, Par Value $0.001 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-4.1
from 8-K/A 19 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.2
from 8-K 3 pages Re: Amendment to Existing Preferred Investment Options Dear Holder: Reference Is Hereby Made to the Registered Offering on or About the Date Hereof (The “Offering”) by NRX Pharmaceuticals, Inc. (The “Company”) of Its Common Stock, Par Value $0.001 Per Share (“Common Stock”), and/or Other Securities of the Company (Collectively, the “Securities”)
12/34/56
EX-4.1
from 8-K 19 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K/A 15 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant NRX Pharmaceuticals, Inc
12/34/56
EX-4.8
from 10-K 6 pages Description of Registrant's Securities
12/34/56
EX-4.8
from 10-K 6 pages Description of Registrant's Securities
12/34/56
EX-4.3
from 8-K 14 pages Form of Unit Purchase Option for the Purchase of 600,000 Units of Big Rock Partners Acquisition Corp
12/34/56
EX-4.2
from 8-K 11 pages Warrant Agreement
12/34/56